New research: 3D structure tumors in immunotherapy

Written by Joseph Mark Robertson New work from cancer researchers at the Department of Cellular Therapy could help to streamline the development of exciting new immunotherapy approaches for treating cancer. Cancer treatments that aim to switch on a patient’s immune system to kill tumor cells – so-called immunotherapy approaches – have received much attention and encouraging […]

International speakers at Cancer Crosslinks

How can research help implement the next wave of precision oncology for patients? Meet the experts behind the research.   These leading international experts are part of the programme at Oslo Cancer Cluster Innovation Park, 17 January. Not signed up for the 11thCancer Crosslinks yet? Join in here!   Professor Naiyer Rizvi is an internationally recognized leader in the treatment […]

Machine-learning for immunotherapy

A prestigious EU-grant will advance OncoImmunity’s machine-learning approach to develop personalized cancer immunotherapy. The bioinformatics company OncoImmunity AS is empowering cancer immunotherapy with artificial intelligence. They use innovative software solutions to guide the discovery of neoantigen-based personalized immunotherapies and biomarkers. What does this really mean? It means that the software they have developed helps to identify […]

Industrial precision against cancer 

Kongsberg Beam Technology wants to direct the precision technology from advanced industrial control systems to hit tumors in the human body.  — We want to use Norwegian spearhead technology to combat cancer, Per Håvard Kleven said from the stage as he pitched the idea of his start-up at the DNB Nordic Healthcare Conference 2018. He is […]

Days to partner up

Roche is looking for new partners in the innovative Norwegian life science scene.  Roche is one of the largest pharmaceutical companies in the world with about 800 ongoing clinical trials. Within cancer research and development, this translates into about 500 clinical trials for many different types of cancer. Roche is a member in Oslo Cancer Cluster.  […]